TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Sana Pharma Medical AS
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
42,346
|
37,544
|
43,590 |
| Financial expenses |
2,003
|
942
|
740 |
| Earnings before taxes |
-6,199
|
-6,939
|
-469 |
| Total assets |
50,799
|
43,622
|
33,257 |
| Current assets |
39,958
|
31,108
|
20,450 |
| Current liabilities |
54,528
|
38,343
|
23,094 |
| Equity capital |
-3,729
|
2,600
|
10,164 |
| - share capital |
19
|
20
|
21 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
-7.3%
|
6.0%
|
30.6% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-14.6%
|
-18.5%
|
-1.1% |
| Return on assets (ROA) |
-8.3%
|
-13.7%
|
0.8% |
| Current ratio |
73.3%
|
81.1%
|
88.6% |
| Return on equity (ROE) |
166.2%
|
-266.9%
|
-4.6% |
| Change turnover |
6,687
|
-3,368
|
-1,293 |
| Change turnover % |
19%
|
-8%
|
-3% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.